NEW YORK (GenomeWeb News) – Nanogen today said that it will collaborate with Italian firm A. Menarini Diagnostics to sell CE-marked in vitro diagnostic kits based on Nanogen’s MGB technology for infectious diseases.
 
Nanogen will manufacture the kits, which will be branded as Menarini products and sold by the Italian firm in Europe. The San Diego-based firm did not disclose which infectious diseases the molecular diagnostic test kits will target, but it said products would be introduced to the market in 2009.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.